XML 44 R32.htm IDEA: XBRL DOCUMENT v3.21.2
STOCKHOLDERS' EQUITY (Tables)
9 Months Ended
Sep. 30, 2021
STOCKHOLDERS' EQUITY  
Schedule of dividend distributions

The following table details the Company’s dividend activity for the nine months ended September 30, 2021 and 2020 (amounts in thousands, except per share data):

    

Total

    

    

    

Dividend Paid

 

Cash

    

Stock

Declaration Date (a)

    

Dividend

    

Payable Date

    

Record Date

    

Cash %

 

Stock %

 

Issued

    

Issued

March 12, 2021

$

9,329

April 7, 2021

March 24, 2021

100.0

n/a

$

9,329

n/a

June 10, 2021

$

9,330

July 9, 2021

June 25, 2021

100.0

n/a

$

9,330

n/a

September 14, 2021

$

9,398

October 7, 2021

September 27, 2021

100.0

n/a

$

9,398

n/a

March 13, 2020

$

9,037

April 7, 2020

March 24, 2020

100.0

n/a

$

9,037

n/a

June 10, 2020 (b)(c)

$

9,068

July 31, 2020

June 22, 2020

50.0

50.0

$

4,537

263

September 9, 2020 (b)(d)

$

9,198

October 29, 2020

September 21, 2020

75.0

25.0

$

6,901

141

(a)A dividend of $0.45 per share was declared in each period indicated.
(b)Stockholders were entitled to elect whether the dividend payable to them would be paid in cash or shares of the Company’s common stock at the percentages indicated, subject to certain limitations.
(c)The shares of common stock issued were valued at approximately $17.22 per share.
(d)The shares of common stock issued were valued at approximately $16.27 per share.
Schedule of equity incentive plans

The following is a summary of the activity of the equity incentive plans:

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

    

2021

    

2020

    

2021

    

2020

Restricted stock grants:

Number of shares

151,500

149,550

Average per share grant price

$

$

$

20.34

$

28.10

Deferred compensation to be recognized over vesting period

$

$

$

3,082,000

$

4,202,000

Number of non-vested shares:

Non-vested beginning of period

707,050

701,675

701,675

674,250

Grants

151,500

149,550

Vested during period

(145,725)

(122,125)

Forfeitures

(500)

(900)

Non-vested end of period

706,550

701,675

706,550

701,675

RSU grants:

Number of underlying shares

80,700

75,026

80,700

75,026

Average per share grant price

$

30.46

$

17.31

$

30.46

$

17.31

Deferred compensation to be recognized over vesting period

$

1,647,000

$

861,000

$

1,647,000

$

861,000

Number of non-vested shares:

Non-vested beginning of period

150,052

148,776

223,802

225,026

Grants

80,700

75,026

80,700

75,026

Vested during period

(73,750)

(24,343)

Forfeitures

(51,907)

Non-vested end of period

230,752

223,802

230,752

223,802

Restricted stock and RSU grants (based on grant price):

Weighted average per share value of non-vested shares

$

25.04

$

24.98

$

25.04

$

24.98

Value of stock vested during the period

$

$

$

5,165,000

$

3,589,000

Weighted average per share value of shares forfeited during the period

$

24.84

$

$

24.57

$

24.03

Total charge to operations:

Outstanding restricted stock grants

$

871,000

$

885,000

$

2,859,000

$

2,644,000

Outstanding RSUs

292,000

251,000

1,332,000

797,000

Total charge to operations

$

1,163,000

$

1,136,000

$

4,191,000

$

3,441,000